Predicting response and survival in chemotherapy-treated triple-negative breast cancer
Prat, A, Lluch, A, Albanell, J, Barry, W T, Fan, C, Chacón, J I, Parker, J S, Calvo, L, Plazaola, A, Arcusa, A, Seguí-Palmer, M A, Burgues, O, Ribelles, N, Rodriguez-Lescure, A, Guerrero, A, Ruiz-Borrego, M, Munarriz, B, López, J A, Adamo, B, Cheang, M C U, Li, Y, Hu, Z, Gulley, M L, Vidal, M J, Pitcher, B N, Liu, M C, Citron, M L, Ellis, M J, Mardis, E, Vickery, T, Hudis, C A, Winer, E P, Carey, L A, Caballero, R, Carrasco, E, Martín, M, Perou, C M, Alba, E
Published in British journal of cancer (14.10.2014)
Published in British journal of cancer (14.10.2014)
Get full text
Journal Article
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
Ruddy, K.J., Pitcher, B.N., Archer, L.E., Cohen, H.J., Winer, E.P., Hudis, C.A., Muss, H.B., Partridge, A.H.
Published in Annals of oncology (01.12.2012)
Published in Annals of oncology (01.12.2012)
Get full text
Journal Article
Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
Tanioka, M, Fan, C, Carey, LA, Hyslop, T, Pitcher, BN, Parker, JA, Hoadley, KA, Henry, NL, Tolaney, S, Dang, C, Krop, IE, Harris, L, Berry, DA, Mardis, E, Perou, CM, Winer, EP, Hudis, CA
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
Ruddy, K J, Pitcher, B N, Archer, L E, Cohen, H J, Winer, E P, Hudis, C A, Muss, H B, Partridge, A H
Published in Annals of oncology (01.12.2012)
Get full text
Published in Annals of oncology (01.12.2012)
Journal Article
BEYOND MAXIMUM GRADE: A NOVEL, LONGITUDINAL TOXICITY OVER TIME (TOXT) ADVERSE EVENT ANALYSIS OF LENALIDOMIDE IN FOLLICULAR LYMPHOMA IN CALGB 50401 (ALLIANCE)
Thanarajasingam, G., Dueck, A.C., Novotny, P.J., Witzig, T.E., Habermann, T.M., Nowakowski, G.S., Flowers, C.R., Bartlett, N.L., Blum, K.A., Pitcher, B.N., Jung, S., Atherton, P.J., Tan, A.D., Sloan, J.A., Leonard, J.P.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
Abstract P2-10-01: PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy
Liu, MC, Pitcher, BN, Mardis, ER, Davies, SR, Snider, JE, Vickery, T, Reed, JP, DeSchryver, K, Singh, B, Friedman, PN, Gradishar, WJ, Perez, EA, Martino, S, Citron, ML, Norton, L, Winer, EP, Hudis, CA, Perou, CM, Ellis, MJ, Barry, WT
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article